|
WO2021028919A1
|
|
Methods and compositions for preventing skin toxicities caused by biological targeted cancer drugs
|
|
WO2020089897A1
|
|
Combination of m-opioid receptor (mor) modulators for preventing and treating pain, suicidality and mental disorders
|
|
US2020345868A1
|
|
Non-metallic magnetic resonance contrast agent
|
|
WO2019053729A1
|
|
An enriched artificial cerebrospinal fluid compositions methods for preparation of same and uses thereof
|
|
WO2018087763A1
|
|
Methods and systems for diagnostics
|
|
AU2017260881A1
|
|
Hyperimmune colostrum in the modulation and treatment of conditions associated with the mammailan microbiome
|
|
AU2011290478A1
|
|
Anti-LPS enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
|
|
AU2010243205A1
|
|
Anti-LPS enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
|
|
AU2010204100A1
|
|
Tissue regeneration membrane
|
|
AU2009233369A1
|
|
Motor neurons developed from stem cells
|
|
EP2886646A1
|
|
Stem cell-derived retinal pigment epithelial cells
|
